Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating crovalimab as adjunct therapy to prevent vaso-occlusive episodes in sickle cell disease has completed, reporting on efficacy, safety, p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Crovalimab (crovalimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED